
High Cancer-Specific Expression of Mesothelin (MSLN) Is Attributable to an Upstream Enhancer Containing a Transcription Enhancer Factor Dependent MCAT Motif
Hucl, T., Brody, J. R., Gallmeier, E., Iacobuzio-Donahue, C. A., Farrance, I. K., Kern, S. E.Volume:
67
Langue:
english
Journal:
Cancer Research
DOI:
10.1158/0008-5472.CAN-07-0474
Date:
October, 2007
Fichier:
PDF, 895 KB
english, 2007